Effect of plasil on criterias of gastric emptying

Phase 3

• Conditions: Aspiration.

• Registration Number: IRCT20120430009593N12
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All patients who are admitted to the operating room of Imam Hossein Hospital with an NPO time of fewer than 8 hours for solids or less than 1 hour for clear fluids
Have enough time to do ultrasound and study
Patient consent after explanation
No contraindication for the administration of plasil
The patient has the ability to position himself properly for the ultrasound
The patient does not have gastrointestinal obstruction
The patient has no history of gastric surgery
Do not have hyaline rickets
The patient has no history of diabetes
BMI < 35
The patient has no reflux problem
The patient should not be treated with stimulants or gastrointestinal drugs

Exclusion Criteria

After administration of plasil or placebo, the patient consumes food or water
Vomiting after administration of plasil or placebo

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gastric antral grade. Timepoint: Measurement of gastric antrum at baseline and 30 min after injection. Method of measurement: Ultrasound.

Secondary Outcome Measures

Name	Time	Method
Decrease in Aspiration Mortality. Timepoint: Gastric antrum measurement at baseline and 30 min after injection. Method of measurement: Ultrasound.